1
|
Hobbs M, Marek L, Young A, Willing E, Dawson P, McIntyre P. Examining spatial variation for immunisation coverage in pregnant women: A nationwide and geospatial retrospective cohort study in Aotearoa New Zealand. Soc Sci Med 2023; 335:116228. [PMID: 37722144 DOI: 10.1016/j.socscimed.2023.116228] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2022] [Revised: 08/03/2023] [Accepted: 09/05/2023] [Indexed: 09/20/2023]
Abstract
BACKGROUND Maternal influenza and pertussis immunisation is crucial for protecting mothers during pregnancy and their babies in the first weeks of life against severe disease. We examined geospatial variation in maternal immunisation coverage among pregnant women in Aotearoa New Zealand and its health equity implications. METHOD We constructed a retrospective cohort including all pregnant women who delivered between 01 January 2013 and 31 December 2020 using administrative health datasets. Our outcomes were receipt of influenza or pertussis vaccine in any one of three relevant national databases (e.g. National Immunisation Register, Proclaims, or Pharmaceutical collection) during the eligible pregnancy. RESULTS Data from our retrospective cohort study show significant regional variation in maternal immunisation coverage for both influenza and pertussis from 2013 to 2020. Maximal coverage was around 50% in the best performing regions, which means that half of the women who were pregnant (183,737 women) were not protected. In addition, we found significant spatio-temporal variation and clustering of immunisation coverage. Our findings are interactively available to explore here: https://geohealthlab.shinyapps.io/hapumama/ CONCLUSION: Our study is one of the first to examine spatial variation in maternal vaccination coverage in pregnant women at a national level over space and time. This provides powerful tools to measure the impact of interventions to improve coverage at national and regional levels, with specific reference to inequities between ethnic groups, likely applicable to similar settings internationally.
Collapse
Affiliation(s)
- M Hobbs
- Faculty of Health, Te Kaupeka Oranga, University of Canterbury, Te Whare Wānanga o Waitaha, Christchurch, Otautahi, Aotearoa, New Zealand; GeoHealth Laboratory, Te Taiwhenua o te Hauora, Geospatial Research Institute Toi Hangarau, University of Canterbury, Te Whare Wānanga o Waitaha, Christchurch, Otautahi, Aotearoa, New Zealand.
| | - L Marek
- GeoHealth Laboratory, Te Taiwhenua o te Hauora, Geospatial Research Institute Toi Hangarau, University of Canterbury, Te Whare Wānanga o Waitaha, Christchurch, Otautahi, Aotearoa, New Zealand
| | - A Young
- School of Pharmacy, He Rau Kawakawa, University of Otago, Te Whare Wānanga o Ōtākou, Dunedin, Ōtepoti, Aotearoa, New Zealand
| | - E Willing
- Kōhatu Centre for Hauora Maori I Division of Health Sciences I Te Whare Wānanga o Ōtākou, University of Otago I Dunedin, Aotearoa, New Zealand
| | - P Dawson
- Women's & Children's Health, Dunedin School of Medicine, University of Otago, Te Whare Wānanga o Ōtākou, Dunedin, Ōtepoti, Aotearoa, New Zealand
| | - P McIntyre
- Women's & Children's Health, Dunedin School of Medicine, University of Otago, Te Whare Wānanga o Ōtākou, Dunedin, Ōtepoti, Aotearoa, New Zealand
| |
Collapse
|
2
|
Clothier HJ, Lawrie J, Lewis G, Russell M, Crawford NW, Buttery JP. SAEFVIC: Surveillance of adverse events following immunisation (AEFI) in Victoria, Australia, 2018. ACTA ACUST UNITED AC 2020; 44. [PMID: 32536336 DOI: 10.33321/cdi.2020.44.46] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Background SAEFVIC is the Victorian surveillance system for adverse events following immunisation (AEFI). It enhances passive surveillance by also providing clinical support and education to vaccinees and immunisation providers. This report summarises surveillance, clinical and vaccine pharmacovigilance activities of SAEFVIC in 2018. Methods A retrospective observational cohort study of AEFI reports received by SAEFVIC in 2018, compared with previous years since 2008. Data were categorised by vaccinee demographics of age, sex, pregnancy and Indigenous status, vaccines administered and AEFI reactions reported. Age cohorts were defined as infant (0-12 months); young child (1-4 years); school-aged (5-17 years); adult (18-64 years); and older person (65+ years). Proportional reporting ratios were calculated for signal investigation of serious adverse neurological events with all vaccines and with influenza vaccines. Clinical support services and educational activities are described. Results SAEFVIC received 1730 AEFI reports (26.8 per 100,000 population), with 9.3% considered serious. Nineteen percent (n = 329) attended clinical review. Annual AEFI reporting trends increased for infants, children and older persons, but were stable for school-aged and adult cohorts. Females comprised 55% of all reports and over 80% of reports among adults. There were 17 reports of AEFI in pregnant women and 12 (0.7%) in persons identifying as Indigenous Australians. A possible signal regarding serious adverse neurological events (SANE) was detected, but was not supported by signal validation testing. A clinical investigation is ongoing. Two deaths were reported coincident to immunisation with no evidence of causal association. Conclusion SAEFVIC continues to provide robust AEFI surveillance supporting vaccine safety monitoring in Victoria and Australia, with new signal detection and validation methodologies strengthening capabilities.
Collapse
Affiliation(s)
- Hazel J Clothier
- SAEFVIC, Murdoch Children's Research Institute, Melbourne, Victoria, Australia; Monash Centre for Health Research Implementation, Monash University, Clayton, Victoria, Australia; School of Population & Global Health, University of Melbourne, Parkville, Victoria, Australia
| | - Jock Lawrie
- SAEFVIC, Murdoch Children's Research Institute, Melbourne, Victoria, Australia; Monash Centre for Health Research Implementation, Monash University, Clayton, Victoria, Australia
| | - Georgina Lewis
- SAEFVIC, Murdoch Children's Research Institute, Melbourne, Victoria, Australia
| | - Melissa Russell
- School of Population & Global Health, University of Melbourne, Parkville, Victoria, Australia
| | - Nigel W Crawford
- SAEFVIC, Murdoch Children's Research Institute, Melbourne, Victoria, Australia; Immunisation Service, Royal Children's Hospital, Parkville, Victoria, Australia; Department Paediatrics, University of Melbourne, Parkville, Victoria, Australia
| | - Jim P Buttery
- SAEFVIC, Murdoch Children's Research Institute, Melbourne, Victoria, Australia; Monash Centre for Health Research Implementation, Monash University, Clayton, Victoria, Australia; Monash Immunisation, Monash Health, Clayton, Victoria, Australia
| |
Collapse
|